Preclinical evaluation of sunitinib, a multi-tyrosine kinase inhibitor, as a radiosensitizer for human prostate cancer

BACKGROUND: Many prostate cancers demonstrate an increased expression of growth factor receptors such as vascular endothelial growth factor receptor (VEGFR) and platelet derived growth factor receptor (PDGFR) which have been correlated with increased resistance to radiotherapy and poor prognosis in...

Descripción completa

Detalles Bibliográficos
Autores principales: Brooks, Colin, Sheu, Tommy, Bridges, Kathleen, Mason, Kathy, Kuban, Deborah, Mathew, Paul, Meyn, Raymond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494537/
https://www.ncbi.nlm.nih.gov/pubmed/22967802
http://dx.doi.org/10.1186/1748-717X-7-154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494537/
https://www.ncbi.nlm.nih.gov/pubmed/22967802
http://dx.doi.org/10.1186/1748-717X-7-154

Ejemplares similares